Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Other Non-Current Liabilities (2021 - 2025)

BioAtla (BCAB) has 5 years of Other Non-Current Liabilities data on record, last reported at $19.8 million in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $19.8 million; the TTM value through Sep 2025 reached $19.8 million, changed 0.0%, while the annual FY2024 figure was $3.8 million, 80.76% down from the prior year.
  • Other Non-Current Liabilities reached $19.8 million in Q3 2025 per BCAB's latest filing, up from $2.2 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $19.8 million in Q4 2021 and bottomed at $1.9 million in Q1 2025.
  • Average Other Non-Current Liabilities over 5 years is $16.6 million, with a median of $19.8 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Liabilities: changed 0.0% in 2022, then tumbled 90.25% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $19.8 million in 2021, then changed by 0.0% to $19.8 million in 2022, then changed by 0.0% to $19.8 million in 2023, then crashed by 80.76% to $3.8 million in 2024, then surged by 419.71% to $19.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $19.8 million in Q3 2025, $2.2 million in Q2 2025, and $1.9 million in Q1 2025.